You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Mental health, behavioural and neurodevelopmental conditions
  5. Psychosis and schizophrenia

Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years

  • Technology appraisal guidance
  • Reference number: TA213
  • Published:  26 January 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Schizophrenia - aripiprazole: final appraisal determination guidance

Schizophrenia - aripiprazole: final appraisal determination guidance Schizophrenia - aripiprazole: final appraisal determination guidance
01 December 2010
(218.8 Kb 3 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 26 November 2010

Back to top